This site is intended for UK Healthcare Professionals only

Education & Training

To help you help your patients, Flynn Pharma provides useful, informative
and focussed clinical tools and patient support materials that can help to
answer those questions that may pop up in consultation.

Add to favourites

No account yet? Register

For Healthcare Professionals
Slenyto® Therapeutic Bulletin

A succinct summary of the evidence-base for Slenyto® (paediatric prolonged-release melatonin) for the treatment of insomnia in children and adolescents with Autistic Spectrum Disorder and/ or Smith-Magenis Syndrome

To request further information on the Therapeutic Bulletin, please contact us.

PRODUCT: Slenyto®
See all Resources

Related Education and Training items

Slenyto® Treatment Goals and Therapy Optimisation – A Guide for Healthcare Professionals

Insomnia in children with ASD is perceived to be one of the most challenging health effects of autism and a successful intervention needs to define realistic and agreed outcomes that can be systematically monitored. This simple guide ...

Find out more

ADHD and ASD

Information for parents of children who may have characteristics or symptoms suggestive of ADHD and/or ASD.

Find out more

Autism and Sleep

A guide for parents and carers of children with autism experiencing difficulty sleeping. This leaflet describes why sleep is important for children with ASD and provides tips on what can be done to improve sleep behaviour and ...

Find out more
More Education & Training